Exploring Patent Litigation and Its Impact on Low-Cost Drug Availability

Impact of Serial Patent Litigation

The Process is the Penalty reveals the adverse effects of serial patent litigation on low-cost drug availability. Brand-name pharmaceutical companies use various tactics to prolong market exclusivity and deter generic competition. This behavior leads to increased healthcare costs, limiting patient access to essential medications.

Consequences for Healthcare

Delays in low-cost drug introduction due to patent litigation create barriers for consumers who rely on affordable medications. The ongoing legal battles drain resources and focus from innovation to litigation—negatively impacting the healthcare system.

Key Points

• Brand-name manufacturers employ tactics to prolong exclusivity.
• Impedes the entry of generic drugs into the market.
• Healthcare costs rise, affecting consumer access.

For more insights into the relationship between patent litigation and drug availability, please visit the original source.